← Back to companies

Octant
0 open
Los Angeles, California, United StatesFounded 201770+ employeesGrowth raisedSeries APrivate
Last round: series b · $80M · Apr 2022(3 rounds total)
Founded by Deepak Agrawal, Ramsey Homsany, Sri Kosuri“Small molecule correctors for protein misfolding, enabled by a synthetic biology, high throughput chemistry + AI platform”
Backed by(18 investors)
Andreessen HorowitzCatalio Capital ManagementWhat If VenturesAllen & CompanyBristol-Myers SquibbFifty YearsBiovergeFlucas Ventures8VCLux CapitalSV Angel
Octant is a well-backed team of experienced technologists and entrepreneurs navigating the complexity of biology and chemistry to develop next generation small molecules. Combining advanced cell engineering, high-throughput chemistry, and automation we are engineering best-in-class drugs across rare disease, oncology, and immunology.
Open Positions at Octant (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Octant?